Davos 2023: Indian Pharma To Be Self-Reliant In 2–3 Years, Says Adar Poonawalla
The Indian pharmaceutical industry will become self-reliant in the next two–three years, Serum Institute of India Pvt.'s Chief Executive Officer Adar Poonawalla said.
Though the pharmaceutical companies are currently dependent on China for active pharmaceutical ingredients and raw materials, they have now begun shifting to local productions, Poonawalla said.
"The cost of some of these drugs may increase as a result," he told BQ Prime's Niraj Shah, on the sidelines of the World Economic Forum in Davos.
As the coronavirus cases in India continue to fall, SII is focusing on developing non-Covid vaccines for diseases like malaria and human papillomavirus or the HPV Infection.
"We have dengue vaccines coming in about two–three years. We hope to roll out a vaccine for five strains of the meningitis bacterial disease that plagues the African continent also," Poonawalla said.
The government's quick regulatory clearances and streamlined procedures have aided the company in "creating newer drugs and innovating much faster", he said.
"It's an exciting time to be a company working and investing in India," Poonawalla said.
Lending And Insurance Business
With the growth of digitisation in India, it has become easier to run a digitised non-banking finance company, in terms of dispensing loans, offering other services and collecting the money, Poonawalla said.
He expects continued credit growth in India.
The company's health insurance business complements its healthcare business, and there are plans to provide "affordable, widespread and good" health insurance to the people in India, he said.
Watch the full interview here:
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
